Physician profile
Eric Wayne Pettyjohn
NPI 1356846299
$320.32
in general payments reported to CMS, 2019-2025
12 companies · $49.42 in 2025
The $49.42 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.64 · 2022: $98.39 · 2023: $60.95 · 2024: $97.92 · 2025: $49.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $82.58 | 2022-2024 | Euflexxa |
| Kerecis Limited | $28.09 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Endo USA, INC. | $26.53 | 2025 | Xiaflex |
| Averitas Pharma INC. | $25.60 | 2023 | Qutenza |
| Biotronik INC. | $24.43 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.02 | 2022 | |
| Reel Surgical, INC. | $22.89 | 2025 | |
| Nevro Corp. | $22.60 | 2023 | Senza |
| Heraeus Medical, LLC. | $19.49 | 2024 | |
| Theragen, INC. | $18.70 | 2022 | |
| Merck Sharp & Dohme LLC | $13.64 | 2019 | |
| Depuy Synthes Sales INC. | $12.75 | 2023 | Monovisc, Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pettyjohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.